These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1686316

  • 1. Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells.
    Taylor JE, Moreau JP, Baptiste L, Moody TW.
    Peptides; 1991; 12(4):839-43. PubMed ID: 1686316
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells.
    Moody TW, Zia F, Makheja A.
    Peptides; 1993; 14(2):241-6. PubMed ID: 8387187
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
    Dorflinger LJ, Schonbrunn A.
    Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
    [Abstract] [Full Text] [Related]

  • 6. Characterization of VIP- and helodermin-preferring receptors on human small cell lung carcinoma cell lines.
    Luis J, Said SI.
    Peptides; 1990 Nov; 11(6):1239-44. PubMed ID: 1965034
    [Abstract] [Full Text] [Related]

  • 7. Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells.
    Castro SW, Buell G, Feniuk W, Humphrey PP.
    Br J Pharmacol; 1996 Feb; 117(4):639-46. PubMed ID: 8646408
    [Abstract] [Full Text] [Related]

  • 8. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
    Virgolini I, Yang Q, Li S, Angelberger P, Neuhold N, Niederle B, Scheithauer W, Valent P.
    Cancer Res; 1994 Feb 01; 54(3):690-700. PubMed ID: 7905785
    [Abstract] [Full Text] [Related]

  • 9. High affinity binding of [125I-Tyr11]somatostatin-14 to human small cell lung carcinoma (NCI-H69).
    Taylor JE, Coy DH, Moreau JP.
    Life Sci; 1988 Feb 01; 43(5):421-7. PubMed ID: 2899828
    [Abstract] [Full Text] [Related]

  • 10. The release of bombesin-like peptides from small cell lung cancer cells.
    Moody TW, Korman LY.
    Ann N Y Acad Sci; 1988 Feb 01; 547():351-9. PubMed ID: 2853597
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ, Schonbrunn A.
    Endocrinology; 1983 Nov 01; 113(5):1551-8. PubMed ID: 6138245
    [Abstract] [Full Text] [Related]

  • 12. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
    Moody TW, Venugopal R, Zia F, Patierno S, Leban JJ, McDermed J.
    Life Sci; 1995 Nov 01; 56(7):521-9. PubMed ID: 7869832
    [Abstract] [Full Text] [Related]

  • 13. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K, Cai RZ.
    Br J Cancer; 1994 Nov 01; 70(5):886-92. PubMed ID: 7947094
    [Abstract] [Full Text] [Related]

  • 14. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
    Moody TW, Zia F, Draoui M, Brenneman DE, Fridkin M, Davidson A, Gozes I.
    Proc Natl Acad Sci U S A; 1993 May 15; 90(10):4345-9. PubMed ID: 8389448
    [Abstract] [Full Text] [Related]

  • 15. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.
    Rivier J, Erchegyi J, Hoeger C, Miller C, Low W, Wenger S, Waser B, Schaer JC, Reubi JC.
    J Med Chem; 2003 Dec 18; 46(26):5579-86. PubMed ID: 14667212
    [Abstract] [Full Text] [Related]

  • 16. Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.
    McKeen ES, Feniuk W, Michel AD, Kidd EJ, Humphrey PP.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov 18; 354(5):543-9. PubMed ID: 8938650
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells.
    Heisler S, Reisine TD, Hook VY, Axelrod J.
    Proc Natl Acad Sci U S A; 1982 Nov 18; 79(21):6502-6. PubMed ID: 6128732
    [Abstract] [Full Text] [Related]

  • 18. Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.
    Cassoni P, Allia E, Marrocco T, Ghè C, Ghigo E, Muccioli G, Papotti M.
    J Endocrinol Invest; 2006 Oct 18; 29(9):781-90. PubMed ID: 17114908
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.